Survodutide: separating the mechanism from the marketing
Purity across our Survodutide samples ranged from 98.2% to 99.4%. Here is the context.
ResearchSurvodutide
Also known as: BI 456906
Moderate evidence
ClassDual GLP-1/glucagon receptor agonist
Research statusPhase 3 clinical trials
CategoryGLP-1 / incretin
Independent tests4
Studies indexed2
Companies tested 3
Overview
A dual agonist pairing GLP-1 activity with glucagon receptor agonism, studied for obesity and for liver-fat endpoints in MASH.
Survodutide is classified as a dual glp-1/glucagon receptor agonist. Its current development status is: phase 3 clinical trials. Human trial data exists but is limited in size, duration or independence; conclusions should be held loosely.
The Peptide Institute tracks Survodutide because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Independently tested companies that sell Survodutide
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
- Companies
- 3
- Samples
- 4
- Updated
- May 30, 2026
- 1 Apex Peptides Exceptional Institute
Top Rated Survodutide98.7% average purity across 1 sample
Purity & Testing 99 Transparency 90 Samples 1 91 View company - 2 Verity Research Chemicals Exceptional
99.4% average purity across 1 sample
Purity & Testing 98 Transparency 92 Samples 1 90 View company - 3 NextGen Peptides Excellent
1 quantity discrepancy across 2 samples
Purity & Testing 91 Transparency 80 Samples 2 85 View company
Research & Studies
Studies library-
Comparative effects of Survodutide on metabolic endpoints
Characterises Survodutide activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.
-
Survodutide in preclinical models: efficacy and translational limits
One of the more methodologically careful entries in the Survodutide literature.
Independent Testing
Testing databaseLaboratory verification of Survodutide products across the companies we index.
Survodutide NextGen Peptides
Purity 98.2% Verified
Survodutide Verity Research Chemicals
Purity 99.4% Verified
Survodutide Apex Peptides
Purity 98.7% Verified
Survodutide NextGen Peptides
Purity 98.4% Discrepancy
Latest Coverage
Survodutide pharmacokinetics: half-life, delivery and the practical implications
A close reading of the Survodutide evidence, without the marketing layer.
Research
Survodutide and the replication problem
4 independently tested samples across 3 companies, and what the results say about Survodutide.
ResearchCommunity Discussions
Forum 163 replies
127 replies
Free download
Get the free Peptide Playbook, plus new breakthroughs as they happen.
What peptides are, why people are using them, and what results people are talking about, in plain English. Sign up and we email you the Playbook right away.
- The Peptide Playbook, free in your inbox
- Occasional updates on new developments
- No spam, unsubscribe anytime